ClinicalTrials.Veeva

Menu

A Study Evaluating the Effect of Etoricoxib and Indomethacin in the Treatment of Acute Gout (0663-081)(COMPLETED)

Organon logo

Organon

Status and phase

Completed
Phase 4

Conditions

Acute Gout

Treatments

Drug: Comparator: indomethacin 75 mg sustained release capsule / Duration of Treatment: 5 Days
Drug: MK0663; etoricoxib / Duration of Treatment: 5 Days

Study type

Interventional

Funder types

Industry

Identifiers

NCT00142558
0663-081
2005_062
MK0663-081

Details and patient eligibility

About

A study to evaluate the effects of etoricoxib and indomethacin in the treatment of acute gout.

Enrollment

180 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Males or females at least 18 years of age who have acute gout.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems